PTC Therapeutics, Inc. Change in Cash

Change in Cash of PTCT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in Cash growth rates and interactive chart.


Highlights and Quick Summary

  • Change in Cash for the quarter ending June 30, 2022 was $22.6 Million (a -149.55% decrease compared to previous quarter)
  • Year-over-year quarterly Change in Cash increased by 80.96%
  • Annual Change in Cash for 2021 was $-19.1 Million (a -75.9% decrease from previous year)
  • Annual Change in Cash for 2020 was $-79.2 Million (a -162.85% decrease from previous year)
  • Annual Change in Cash for 2019 was $126 Million (a 118.4% increase from previous year)
  • Twelve month Change in Cash ending June 30, 2022 was $-10.6 Million (a 332.03% increase compared to previous quarter)
  • Twelve month trailing Change in Cash decreased by -95.66% year-over-year
Trailing Change in Cash for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$-10.6 Million $-2.45 Million $-19.1 Million $-244 Million
Visit stockrow.com/PTCT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in Cash of PTC Therapeutics, Inc.

Most recent Change in Cashof PTCT including historical data for past 10 years.

Interactive Chart of Change in Cash of PTC Therapeutics, Inc.

PTC Therapeutics, Inc. Change in Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $22.57 $-45.54
2021 $-0.1 $12.47 $30.72 $-62.18 $-19.09
2020 $-225.16 $275.51 $35.17 $-164.74 $-79.22
2019 $-235.55 $394.98 $-65.05 $31.65 $126.03
2018 $-37.42 $-16.88 $126.11 $-14.12 $57.71
2017 $-30.05 $8.83 $78.91 $-4.22 $53.47
2016 $8.04 $14.63 $-4.51 $-17.86 $0.3
2015 $-82.69 $111.49 $-7.61 $-12.92 $8.27
2014 $-3.13 $31.7 $-94.68 $100.44 $34.33
2013 $-8.63 $-130.05 $103.85 $47.52 $12.69
2012 $-11.74 $-7.78 $12.88 $-19.07 $-25.71
2011 $-0.24 $-0.24

Business Profile of PTC Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology